| RS2527832764 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527833201 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527833277 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527833447 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527833719 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527834566 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527834624 |
LMNA
|
Health Risk |
Likely pathogenic |
Sick sinus syndrome, Sick sinus syndrome |
| RS2527834799 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2527835305 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527835731 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527835812 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527835876 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2527835936 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527838026 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527838259 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527838316 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527838437 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527838648 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527839053 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527840110 |
MYOC
|
Health Risk |
Likely pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS2527842814 |
LBR
|
Health Risk |
Pathogenic |
— |
| RS2527844947 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527854627 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527857747 |
GJC2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Lymphatic malformation 3 |
| RS2527875152 |
GJC2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2527875494 |
GJC2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2527875902 |
GJC2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2527876961 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 2, Spastic paraplegia |
| RS2527877227 |
GJC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 2, Hypomyelinating leukodystrophy 2 |
| RS2527880529 |
WDR35
|
Health Risk |
Likely pathogenic |
WDR35-related disorder, WDR35-related disorder |
| RS2527880578 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527880646 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2527880675 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527882185 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527882862 |
WDR35
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS2527884093 |
SLC30A10
|
Health Risk |
Likely pathogenic |
Hypermanganesemia with dystonia, polycythemia |
| RS2527885160 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527885321 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527886589 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527888341 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527888357 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527889197 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527889928 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527890301 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527890315 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527890422 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527890446 |
HNRNPU
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS2527893248 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527894074 |
HNRNPU
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527894182 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527894355 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527894841 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527894863 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527895152 |
HNRNPU
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 54 |
| RS2527895328 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527895448 |
HNRNPU
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527895727 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527895995 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527896284 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527896376 |
HNRNPU
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527899567 |
IBA57
|
Health Risk |
Likely pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS2527901415 |
IBA57
|
Health Risk |
Likely pathogenic |
— |
| RS2527901443 |
IBA57
|
Health Risk |
Pathogenic |
Multiple mitochondrial dysfunctions syndrome 3, Multiple mitochondrial dysfunctions syndrome 3 |
| RS2527903495 |
WDR35
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS2527905126 |
NBAS
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2527909396 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527910800 |
NCF2
|
Health Risk |
Pathogenic |
Chronic granulomatous disease, Granulomatous disease |
| RS2527911236 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2527911315 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2527918499 |
KIDINS220
|
Health Risk |
Likely pathogenic |
— |
| RS2527921101 |
IBA57
|
Health Risk |
Conflicting classifications of pathogenicity |
C1orf69/IBA57-related disorder, Multiple mitochondrial dysfunctions syndrome 3 |
| RS2527924310 |
MYCN
|
Health Risk |
Conflicting classifications of pathogenicity |
MYCN-related disorder, Megalencephaly-polydactyly syndrome |
| RS2527924479 |
WDR35
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS2527925277 |
MYCN
|
Health Risk |
Likely pathogenic |
MYCN-related disorder, MYCN-related disorder |
| RS2527925425 |
MYCN
|
Health Risk |
Likely pathogenic |
— |
| RS2527925514 |
MYCN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527925687 |
MYCN
|
Health Risk |
Pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS2527926022 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527927539 |
MYCN
|
Health Risk |
Pathogenic/Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS2527927639 |
MYCN
|
Health Risk |
Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS2527928565 |
MYCN
|
Health Risk |
Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS2527930575 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2527930725 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2527935561 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2527935805 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS2527936127 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS2527936480 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527936786 |
MYCN
|
Health Risk |
Likely pathogenic |
MYCN-related disorder, MYCN-related disorder |
| RS2527936871 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527936976 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2527936984 |
MYCN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527937180 |
LMNA
|
Health Risk |
Likely pathogenic |
Congenital muscular dystrophy due to LMNA mutation, Congenital muscular dystrophy due to LMNA mutation |
| RS2527937650 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2527938178 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2527938548 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2527938896 |
MYCN
|
Health Risk |
Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS2527938946 |
MYCN
|
Health Risk |
Likely pathogenic |
— |
| RS2527939511 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2527946248 |
NCF2
|
Health Risk |
Pathogenic |
Chronic granulomatous disease, Chronic granulomatous disease |
| RS2527949922 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |